Haematology Research Review, Issue 51

In this issue:

RIC vs. MAC before allogeneic transplantation in MDS
Long-term follow-up of contemporary early-stage Hodgkin’s treatment
Impact of expert review of lymphoma diagnoses
Taller height increases VTE risk
Differential major bleeding risks for LMWHs
Fedratinib (JAK-2 inhibitor) for myelofibrosis
Monoclonal B-cell lymphocytosis in UK and Ugandan populations
Predicting outcomes for MDS, and AML from MDS, postallogeneic HCT
Circulating cell-free DNA for diagnosis and predicting prognosis in lymphoma

Please login below to download this issue (PDF)